References
- Anon. (2009). Immunoscan Anti-GBM Immunoassay. Instruction Manual. Malmö, Sweden: Euro-Diagnostica.
- Barnabe, C. & Fahlman, N. (2008). Overlapping clinical features of lupus and leptospirosis. Clinical Rheumatology, 27 (Suppl. 1), S23—S25.
- Constantin, A., Mann, F., Oksman, F. & Bouteiller, G. (1996). Antineutrophil cytoplasmic antibodies in leptospirosis. Journal of Rheumatology, 23, 411.
- Craig, S. B., Graham, G. C., Burns, M.-A., Dohnt, M. F., Wilson, R. J., Smythe, L. D. & McKay, D. B. (2009). Leptospirosis and Goodpasture's syndrome: is there an eitological link. Bioscience Hypotheses, 2, 190-191.
- Daher, E. F., Oliveira Neto, F. H. & Ramirez, S. M. P. (2002). Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis. Revista do Institut° de Medicina Tropical de Sao Paulo, 44, 85-90.
- Faine, S. (1982). Guidelines for the Control of Leptospirosis, Geneva: World Health Organization.
- Goodpasture, E. W. (1919). The significance of certain pulmonary lesions in relation to the etiology of influenza. American Journal of Medical Science, 158, 863–871.
- Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. (2003). Alport's syndrome, Goodpasture's syndrome and type IV collagen. New England Journal of Medicine, 348, 2543–2556.
- Lai, K. N., Aarons, I., Woodroffe, A. J. & Clarkson, A. R. (1982). Renal lesions in leptospirosis. Australian and New Zealand Journal of Medicine, 12, 276–279.
- Levett, P. N. (2001). Leptospirosis. Clinical Microbiology Reviews, 14, 296–326.
- McClain, J. B., Ballou, W. R., Harrison, S. M. & Steinweg, D. L. (1984). Doxycyclin therapy for leptospirosis. Annals of Internal Medicine, 100, 696–698.
- Nally, J. E., Chantranuwat, C., Wu, X.-Y., Fishbein, M. C., Pereira, M. M., da Silva, J. J. P., Blanco, D. R. & Lovett, M. A. (2004). Alveolar septal deposition of immunoglobulin and complement parallels pulmon-ary haemorrhage in a guinea pig model of severe pulmonary leptospirosis. American Journal of Pathology, 163, 1115–1127.
- Pappas, G., Akritidis, N., Christou, L., Mastora, M. & Tsianos, E. (2003). Unusual causes of reactive arthritis: leptospirosis and Co:ciella burnetii. Clinical Rheumatology, 22, 343–346.
- Santiago, M., Martinelli, R., Ko, A., Reis, E. A., Fontes, R. D., Nascimento, E. G., Pierangeli, S., Espinola, R. & Gharavi, A. (2001). Anti-2 glycopro-tein I and anticardiolipin antibodies in leptospirosis, syphilis and kala-azar. Clinical and Experimental Rheumatology, 19, 425–430.
- Stanton, M. C. & Tange, J. D. (1958). Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australasian Annals of Medicine, 7, 132–144.
- Tattevin, P., Dupeux, S. & Hoff, J. (2003). Leptospirosis and the antiphospholipid syndrome. American Journal of Medicine, 114, 164.
- Verma, A., Artiushin, S., Matsunaga, J., Haake, D. A. & Timoney, J. F. (2005). LruA and LruB novel lipoproteins of pathogenic Leptospira interrogans associated with equine recurrent uveitis. Infection and Immunity, 73, 7259–7266.
- Verma, A., Rathinarn, S. R., Gown Priya, C., Muthukkaruppan, V. R., Stevenson, B. & Timoney, J. F. (2008). LruA and LruB antibodies in sera of humans with leptospiral uveitis. Clinical and Vaccine Immunology, 15, 1019–1023.
- Watt, G., Padre, L. P., Tuazon, M. L., Calubaquib, C., Santiago, E., Ranoa, C. P. & Laughlin, L. W. (1988). Placebo-controlled trial of intravenous penicillin for severe late leptospirosis. Lancet, i, 433–435.
- Wieslander, J. & Heinegfird, D. (1985). The involve-ment of type 4 collagen in Goodpasture syndrome. Annals of the New York Academy of Sciences, 460, 363–374.
- World Health Organization (2003). Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Valletta: WHO.